143 related articles for article (PubMed ID: 8630595)
21. High-Flow Nasal Cannula Therapy for Exertional Dyspnea in Patients with Cancer: A Pilot Randomized Clinical Trial.
Hui D; Mahler DA; Larsson L; Wu J; Thomas S; Harrison CA; Hess K; Lopez-Mattei J; Thompson K; Gomez D; Jeter M; Lin S; Basen-Engquist K; Bruera E
Oncologist; 2021 Aug; 26(8):e1470-e1479. PubMed ID: 33289280
[TBL] [Abstract][Full Text] [Related]
22. Oxygen may improve dyspnea and endurance in patients with chronic obstructive pulmonary disease and only mild hypoxemia.
Dean NC; Brown JK; Himelman RB; Doherty JJ; Gold WM; Stulbarg MS
Am Rev Respir Dis; 1992 Oct; 146(4):941-5. PubMed ID: 1416422
[TBL] [Abstract][Full Text] [Related]
23. Management of dyspnea in advanced cancer patients.
Ripamonti C
Support Care Cancer; 1999 Jul; 7(4):233-43. PubMed ID: 10423049
[TBL] [Abstract][Full Text] [Related]
24. Effect of ambulatory oxygen on exertional dyspnea in IPF patients without resting hypoxemia.
Nishiyama O; Miyajima H; Fukai Y; Yamazaki R; Satoh R; Yamagata T; Sano H; Iwanaga T; Higashimoto Y; Nakajima H; Kume H; Tohda Y
Respir Med; 2013 Aug; 107(8):1241-6. PubMed ID: 23806287
[TBL] [Abstract][Full Text] [Related]
25. Exertional oxygen of limited benefit in patients with chronic obstructive pulmonary disease and mild hypoxemia.
McDonald CF; Blyth CM; Lazarus MD; Marschner I; Barter CE
Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1616-9. PubMed ID: 7582304
[TBL] [Abstract][Full Text] [Related]
26. Treatment of dyspnea in cancer patients.
Thomas JR; Von Gunten CF
Oncology (Williston Park); 2002 Jun; 16(6):745-50; discussion 750, 755, 758-60. PubMed ID: 12088297
[TBL] [Abstract][Full Text] [Related]
27. A double-blind, randomised, controlled Phase II trial of Heliox28 gas mixture in lung cancer patients with dyspnoea on exertion.
Ahmedzai SH; Laude E; Robertson A; Troy G; Vora V
Br J Cancer; 2004 Jan; 90(2):366-71. PubMed ID: 14735178
[TBL] [Abstract][Full Text] [Related]
28. Oxygen for end-of-life lung cancer care: managing dyspnea and hypoxemia.
Tiep B; Carter R; Zachariah F; Williams AC; Horak D; Barnett M; Dunham R
Expert Rev Respir Med; 2013 Oct; 7(5):479-90. PubMed ID: 24138692
[TBL] [Abstract][Full Text] [Related]
29. Symptomatic benefit of supplemental oxygen in hypoxemic patients with chronic lung disease.
Swinburn CR; Mould H; Stone TN; Corris PA; Gibson GJ
Am Rev Respir Dis; 1991 May; 143(5 Pt 1):913-5. PubMed ID: 2024842
[TBL] [Abstract][Full Text] [Related]
30. The effect of helium and oxygen on exercise performance in chronic obstructive pulmonary disease: a randomized crossover trial.
Laude EA; Duffy NC; Baveystock C; Dougill B; Campbell MJ; Lawson R; Jones PW; Calverley PM
Am J Respir Crit Care Med; 2006 Apr; 173(8):865-70. PubMed ID: 16439720
[TBL] [Abstract][Full Text] [Related]
31. [Respiratory problems in cancer--causes and treatment].
Weber W
Schweiz Rundsch Med Prax; 1992 Jan; 81(1-2):20-2. PubMed ID: 1370589
[TBL] [Abstract][Full Text] [Related]
32. Factor analysis of changes in dyspnea and lung function parameters after bronchodilation in chronic obstructive pulmonary disease.
Taube C; Lehnigk B; Paasch K; Kirsten DK; Jörres RA; Magnussen H
Am J Respir Crit Care Med; 2000 Jul; 162(1):216-20. PubMed ID: 10903244
[TBL] [Abstract][Full Text] [Related]
33. Oxygen-assisted exercise in chronic obstructive lung disease. The effect on exercise capacity and arterial blood gas tensions.
Bradley BL; Garner AE; Billiu D; Mestas JM; Forman J
Am Rev Respir Dis; 1978 Aug; 118(2):239-43. PubMed ID: 697174
[TBL] [Abstract][Full Text] [Related]
34. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
[TBL] [Abstract][Full Text] [Related]
35. Effect of obesity on respiratory mechanics during rest and exercise in COPD.
Ora J; Laveneziana P; Wadell K; Preston M; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2011 Jul; 111(1):10-9. PubMed ID: 21350021
[TBL] [Abstract][Full Text] [Related]
36. [Exercise induced hypoxemia and exercise tolerance in patients with COPD and the benefits of oxygen supplementation].
Kurihara N; Fujimoto S; Kohno M; Ohta K; Hirata K; Takeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Feb; 27(2):155-62. PubMed ID: 2526271
[TBL] [Abstract][Full Text] [Related]
37. Inhaled morphine to relieve dyspnea in advanced cystic fibrosis lung disease.
Janahi IA; Maciejewski SR; Teran JM; Oermann CM
Pediatr Pulmonol; 2000 Sep; 30(3):257-9. PubMed ID: 10973044
[TBL] [Abstract][Full Text] [Related]
38. The effect of bronchodilators and oxygen alone and in combination on self-paced exercise performance in stable COPD.
Cukier A; Ferreira CA; Stelmach R; Ribeiro M; Cortopassi F; Calverley PM
Respir Med; 2007 Apr; 101(4):746-53. PubMed ID: 17000096
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms of exertional dyspnea in patients with cancer.
Travers J; Dudgeon DJ; Amjadi K; McBride I; Dillon K; Laveneziana P; Ofir D; Webb KA; O'Donnell DE
J Appl Physiol (1985); 2008 Jan; 104(1):57-66. PubMed ID: 17975124
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients.
Clemens KE; Klaschik E
J Pain Symptom Manage; 2007 Apr; 33(4):473-81. PubMed ID: 17397708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]